Skin NeoplasmNCT05908435
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
A study testing Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors in people with Skin Neoplasm and Adolescent Behavior, run by Harvard School of Public Health (HSPH) at 1 site in United States.
Trial summary
This study will evaluate the use of publicly available free sunscreen dispensers at Maine beaches and Boston and Cambridge parks. Aim 1: Determine the impact of DFS+ (dispensers, flyers, enhanced signage, + a social media component delivered by teen ambassadors) sun protection education on the use of free sunscreen… Read more about this study
- Who is it for?
- Ages 12 to 20 yearsHealthy volunteers can take part
- Conditions the study is for
- Skin Neoplasm, Adolescent Behavior, Sunscreening Agents
- What is being tested?
- Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,200 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Jun 2023to Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 20 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Being a Boston, MA, Cambridge, MA or Maine youth ages 12-20
- Able to complete a survey in English
Who cannot join
- Not a Boston, MA, Cambridge, MA or Maine youth ages 12-20
- Not able to complete a survey in English
Trial locations and contacts
1 site in 1 country.
United States1 site
Harvard TH Chan School of Public Health
Boston, Massachusetts, 02155
About this study
Official title: Measuring the Impact of Free Sunscreen Dispensers in Community Settings Frequented by Youth
This study will evaluate the use of publicly available free sunscreen dispensers at Maine beaches and Boston and Cambridge parks.
Aim 1: Determine the impact of DFS+ (dispensers, flyers, enhanced signage, + a social media component delivered by teen ambassadors) sun protection education on the use of free sunscreen dispensers by adolescents ages 12-20 compared with DFS (dispensers, flyers, standard signage).
Aim 2: Outcomes evaluation to assess the effects of the sunscreen dispensers and the sun-safety educational intervention on sun protection knowledge, attitudes, beliefs, and behaviors within the community.
Aim 3: Cost Evaluation and Cost-Effectiveness Analysis
Read the detailed description
The investigators will build on the pioneering work of IMPACT Melanoma which has provided free sunscreen dispensers to a general population. This study will build on IMPACT Melanoma's ability to install, maintain, and now for the first time, target and publicize the use of dispensers for a teen population. The investigators will test scalable methods for improving the use of free sunscreen dispensers by testing DFS interventions compared with the addition of social media led by teen ambassadors. The investigators will evaluate the impact of the intervention in both parks and beaches in Boston, MA, Cambridge, MA and Maine.
- Conditions
- Skin Neoplasm, Adolescent Behavior, Sunscreening Agents
- Being tested
- Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors
- Keywords
- Skin Neoplasm, Adolescent Behavior, Sunscreening Agents
- Medical subject headings
- Skin Neoplasms, Adolescent Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadorsBehavioural
The study intervention is designed to increase utilization of free sunscreen dispensers, applying and reapplying sunscreen, and motivating use of other forms of sun protection by teens. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. 'Teen enhanced' signage will be present on the dispenser in the intervention parks/beaches. Teen ambassadors will share 3-5 posts to their social media platform over the course of 1 week encouraging sun protection practices and use of the free sunscreen dispenser (when the intervention is occurring at the study site).
| Study group | Role | What they receive |
|---|---|---|
| Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors | Experimental | The DFS+ experimental group is designed to increase utilization of free sunscreen dispensers, applying and reapplying sunscreen, and motivating use of other forms of sun protection by teens in 8 Boston parks and 2 Maine beaches. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. 'Teen enhanced' signage will be present on the dispenser in the intervention parks/beaches. Teen ambassadors will share 3-5 posts to their social media platform over the course of 1 week encouraging sun protection practices and use of the free sunscreen dispenser (when the intervention is occurring at the study site). Receives: Behavioral: Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors |
| Dispensers, Flyers, Signage | No intervention | The DFS control group includes dispensers, flyers, and standard signage at 8 Boston parks and 2 Maine beaches. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. Standard signage will be present on the dispenser in the control parks/beaches. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dispenser utilization/Measured reduction in sunscreen levels in dispensers
The investigators will count of the number of teens between the ages of 12 and 20 using the sunscreen dispenser in real-time at the park or beach as they are using the dispenser. This will serve as the numerator. The investigators will also conduct observations to determine an estimated number of teens who are the park on a given day. This will serve as the denominator. This count will be in real-time, counting the number of teens who we observe at the park or beach where the study is taking place.
Measured: In real-time, up to 1 day
Reported use of sunscreen from surveys completed by teens
Survey responses about sunscreen use
Measured: In real-time, up to 1 day
Secondary outcomes (1)
Sun prevention practices
Survey responses about sun protection practices
Measured: In real-time, up to 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2023
- Study start3 Jun 2023
- Primary completion31 Aug 2024
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin NeoplasmStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 1,200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Harvard School of Public Health (HSPH)
- Sponsor type
- University, hospital or other
- Collaborators
- Centers for Disease Control and Prevention
- Responsible party
- Principal investigator, Alan Geller, Harvard School of Public Health (HSPH)
- Investigators
- Alan Geller, MPH, RN, Principal investigator, Harvard School of Public Health (HSPH)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05908435
- Sponsor's protocol ID
- IRB22-1402
- Status last verified
- Oct 2024
- First submitted
- 30 May 2023
- Last updated
- 18 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measuring the Impact of Free Sunscreen Dispensers in Community Settings Frequented by Youth
- ClinicalTrials.gov ID
- NCT05908435
- Acronym / sponsor ID
- IRB22-1402
- Conditions
- Skin Neoplasm, Adolescent Behavior, Sunscreening Agents
- Keywords
- Skin Neoplasm, Adolescent Behavior, Sunscreening Agents
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1,200 participants (estimated)
- Lead sponsor
- Harvard School of Public Health (HSPH)University, hospital or other
- Collaborators
- Centers for Disease Control and Prevention
- Study start
- 3 Jun 2023 (actual)
- Primary completion
- 31 Aug 2024 (actual)
- Study completion
- Dec 2025 (estimated)
- First posted
- 18 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will evaluate the use of publicly available free sunscreen dispensers at Maine beaches and Boston and Cambridge parks.
Aim 1: Determine the impact of DFS+ (dispensers, flyers, enhanced signage, + a social media component delivered by teen ambassadors) sun protection education on the use of free sunscreen dispensers by adolescents ages 12-20 compared with DFS (dispensers, flyers, standard signage).
Aim 2: Outcomes evaluation to assess the effects of the sunscreen dispensers and the sun-safety educational intervention on sun protection knowledge, attitudes, beliefs, and behaviors within the community.
Aim 3: Cost Evaluation and Cost-Effectiveness Analysis
Detailed description
The investigators will build on the pioneering work of IMPACT Melanoma which has provided free sunscreen dispensers to a general population. This study will build on IMPACT Melanoma's ability to install, maintain, and now for the first time, target and publicize the use of dispensers for a teen population. The investigators will test scalable methods for improving the use of free sunscreen dispensers by testing DFS interventions compared with the addition of social media led by teen ambassadors. The investigators will evaluate the impact of the intervention in both parks and beaches in Boston, MA, Cambridge, MA and Maine.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors | Experimental | Behavioral: Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadorsThe DFS+ experimental group is designed to increase utilization of free sunscreen dispensers, applying and reapplying sunscreen, and motivating use of other forms of sun protection by teens in 8 Boston parks and 2 Maine beaches. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. 'Teen enhanced' signage will be present on the dispenser in the intervention parks/beaches. Teen ambassadors will share 3-5 posts to their social media platform over the course of 1 week encouraging sun protection practices and use of the free sunscreen dispenser (when the intervention is occurring at the study site). |
| Dispensers, Flyers, Signage | No intervention | –The DFS control group includes dispensers, flyers, and standard signage at 8 Boston parks and 2 Maine beaches. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. Standard signage will be present on the dispenser in the control parks/beaches. |
Who may qualify
- Ages
- 12 to 20 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (2 listed)
- Being a Boston, MA, Cambridge, MA or Maine youth ages 12-20
- Able to complete a survey in English
Key exclusion criteria (2 listed)
- Not a Boston, MA, Cambridge, MA or Maine youth ages 12-20
- Not able to complete a survey in English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadorsThe study intervention is designed to increase utilization of free sunscreen dispensers, applying and reapplying sunscreen, and motivating use of other forms of sun protection by teens. IMPACT Melanoma will install and maintain free sunscreen dispensers at the study sites. Flyers will be posted at locations at the park/beach to inform people of the availability of free sunscreen and the location of the dispenser. 'Teen enhanced' signage will be present on the dispenser in the intervention parks/beaches. Teen ambassadors will share 3-5 posts to their social media platform over the course of 1 week encouraging sun protection practices and use of the free sunscreen dispenser (when the intervention is occurring at the study site). | Behavioural | Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors |
Primary outcome
Dispenser utilization/Measured reduction in sunscreen levels in dispensers
Time frame: In real-time, up to 1 day
The investigators will count of the number of teens between the ages of 12 and 20 using the sunscreen dispenser in real-time at the park or beach as they are using the dispenser. This will serve as the numerator. The investigators will also conduct observations to determine an estimated number of teens who are the park on a given day. This will serve as the denominator. This count will be in real-time, counting the number of teens who we observe at the park or beach where the study is taking place.
Reported use of sunscreen from surveys completed by teens
Time frame: In real-time, up to 1 day
Survey responses about sunscreen use
1 secondary outcome
Sun prevention practices
Time frame: In real-time, up to 1 day
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Oct 2024.
- Individual participant dataSharing planned: No
Related trials for Skin Neoplasm
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alan Geller, MPH, RN principal investigator
Harvard School of Public Health (HSPH)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors in people with Skin Neoplasm and Adolescent Behavior, run by Harvard School of Public Health (HSPH) at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 18 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dispenser utilization/Measured reduction in sunscreen levels in dispensers (time frame: In real-time, up to 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2024.